Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001316118 | SCV001506722 | pathogenic | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2022-09-19 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1017027). This variant has not been reported in the literature in individuals affected with NEXN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg321Lysfs*17) in the NEXN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEXN are known to be pathogenic (PMID: 32058062, 32814711, 32870709, 33949776). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001316118 | SCV002781267 | uncertain significance | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2022-05-05 | criteria provided, single submitter | clinical testing |